asco: fak inhibition for meningiomas with nf2 mutations
Published 4 years ago • 91 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
0:16
nerve tumors neurofibromatosis
-
5:45
neurofibromatosis, causes, signs and symptoms, diagnosis and treatment.
-
1:05
revisiting farnesyltransferase inhibitors for head and neck cancer
-
1:26
what are meningiomas? | cedars-sinai
-
0:59
electrodesiccation for removal of nf tumors
-
5:26
video 216: neurofibromatosis type 1 (nf1) & type 2 (nf2): genes, pathogenesis, and clinical symptoms
-
3:18
enplaque meningioma mgn series
-
4:02
what is neurofibromatosis type 1 (nf1)?
-
5:16
identification of potential common genetic modifiers of neurofibromas, l. pacot et al.
-
2:40
profiling circulating tumor dna to monitor and classify brain lymphomas
-
59:36
mek inhibitors and nf1-associated tumors: molecular mechanisms and targeted approaches
-
2:07:24
collaborations that transform: rare disease neurofibromatosis
-
27:22
falcotentorial meningiomas/james k. liu, md, facs, faans
-
3:47
nf1 versus nf2
-
1:20
mpns at asco 2022: cytopenic myelofibrosis, non-jak inhibitor approaches & combination therapy
-
2:00
asco 2021 - dr. taiga nishihori - abstract 7003
-
3:52
an uncommon case of symptomatic multiple meningiomas with bilateral compressive optic neuropathy
-
0:52
brain tumors and cns metastases at asco 2022
-
2:01
dr. doris hansen at asco 2022: abstract no. 8042